Varian Medical eyes repurchase of 6 million more shares through 2014

Varian Medical Systems ($VAR) will buy back an additional 6 million shares of common stock through 2014. The Palo Alto, CA, maker of radiotherapy-, radiosurgery- and brachytherapy-related medical devices and software has already been in the midst of an 8-million-share repurchase program approved to run between Sept. 29, 2012, and Dec. 31, 2013, with 2 million shares left to go. Varian said the new share repurchase effort, scheduled for Dec. 30, 2013, through Dec. 31, 2014, can take place in the open market or in privately negotiated transactions. Item

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.